REBECCA PELL: Open Payments
NPI 1477161008 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 15 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $346 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $115 |
| ABBVIE INC. | 3 | $78 |
| ViiV Healthcare Company | 2 | $60 |
| Exact Sciences Corporation | 2 | $36 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: APRETUDE, UBRELVY, The Cologuard Plus Collection Kit, XYWAV, Kerendia, MOUNJARO, VRAYLAR, JOURNAVX.
Industry payments across HI — which companies pay providers there.
